Low-Cost Contingency Management for Hispanic Outpatients - 3
Primary Purpose
Substance Abuse
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Contingency management
Sponsored by
About this trial
This is an interventional treatment trial for Substance Abuse focused on measuring contingency management, substance abuse
Eligibility Criteria
Inclusion criteria: age > 18 years current DSM-IV substance dependence. Exclusion criteria: have a serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination have dementia (<23 on the Mini Mental State Exam; Folstein et al. 1975) DSM-IV diagnosis of pathological gambling plans to move from the Hartford are within 9 months.
Sites / Locations
Outcomes
Primary Outcome Measures
Drug use
Secondary Outcome Measures
Full Information
NCT ID
NCT00249548
First Posted
November 3, 2005
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
UConn Health
1. Study Identification
Unique Protocol Identification Number
NCT00249548
Brief Title
Low-Cost Contingency Management for Hispanic Outpatients - 3
Official Title
Low-Cost Contingency Management for Hispanic Outpatients
Study Type
Interventional
2. Study Status
Record Verification Date
May 2008
Overall Recruitment Status
Completed
Study Start Date
August 2004 (undefined)
Primary Completion Date
January 2006 (Actual)
Study Completion Date
January 2006 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
UConn Health
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the effectiveness of a lower-cost contingency management (CM) procedure in Hispanic substance abusing outpatients. Thirty individuals meeting DSM-IV criteria for substance dependence receive one of two conditions: (a) standard treatment, or (b) standard treatment plus prize CM. Using a cross-over design, CM is implemented in a community-based outpatient clinic and compared with non-CM in the same clinic. The participating clinic is randomly assigned to receive either the CM or non-CM phase first; 15 weeks after the final participant in one phase is enrolled, a one-week washout period occurs, followed by a switch to the other phase. Patients initiating outpatient treatment during the non-CM phase receive standard treatment and submit urine and breath samples 2/week during Weeks 1-6 and 1/week during Weeks 7-12. Patients initiating treatment during the CM phase also receive standard treatment and the same breath and urine monitoring. In addition, they earn the opportunity to win prizes for coming to treatment and for submitting negative breath and urine samples. Follow-up interviews are conducted at 1,3,6 and 9 months following intake during which substance use and psychosocial functioning are assessed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance Abuse
Keywords
contingency management, substance abuse
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Contingency management
Primary Outcome Measure Information:
Title
Drug use
Time Frame
baseline and each follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
age > 18 years
current DSM-IV substance dependence.
Exclusion criteria:
have a serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
have dementia (<23 on the Mini Mental State Exam; Folstein et al. 1975)
DSM-IV diagnosis of pathological gambling
plans to move from the Hartford are within 9 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy Petry, Ph.D.
Organizational Affiliation
UConn Health
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Low-Cost Contingency Management for Hispanic Outpatients - 3
We'll reach out to this number within 24 hrs